Placebo of vildagliptin
CLAF237A23156
Approved small_molecule completed
Quick answer
Placebo of vildagliptin for Type 2 Diabetes Mellitus is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed